Lightpath technologies, inc. (lpth) q2 2023 earnings call transcript

Lightpath Technologies, Inc. (NASDAQ:LPTH ) Q2 2023 Earnings Conference Call February 9, 2023 5:00 PM E...

February 9, 2023, 8:47 pm

Gold trades in tight range; cpi data to be key

Gold prices turned negative on Thursday as treasury yields pared losses, with traders awaiting inflation data next week for clues on the U.S. Federal ...

February 9, 2023, 8:29 pm

Lightpath technologies, inc. (lpth) reports q2 loss, tops revenue estimates

Lightpath Technologies, Inc. (LPTH) delivered earnings and revenue surprises of 40% and 13.73%, respect...

February 9, 2023, 7:35 pm

Crypto: regulating crypto staking would be a “terrible path” for retail traders says coinbase ceo brian armstrong

In a series of Tweets on Wednesday night, Coinbase CEO suggested that the SEC could ban crypto staking. Read Full Story The post Crypto: Regulating cr...

February 9, 2023, 3:57 pm

Regeneron's (regn) eylea gets fda nod for rop in infants

Regeneron's (REGN) Eylea gets FDA approval for the treatment of preterm infants with retinopathy of prematurity (ROP)....

February 9, 2023, 3:04 pm

Regulating crypto staking would be a “terrible path” for retail traders says coinbase ceo brian armstrong

A U.S. Securities and Exchange Commission ban on crypto staking would be a “terrible path” for the industry, Brian Armstrong, chief executive and ...

February 9, 2023, 10:57 am

Gbp/usd outlook: bulls seem non-committed, remain at the mercy of usd price dynamics

GBP/USD sticks to modest gains for the third straight day on Thursday, though lacks follow-through. The uncertainty over the Fed’s rate-hike ...

February 9, 2023, 5:29 am

Eylea® (aflibercept) injection approved as the first pharmacologic treatment for preterm infants with retinopathy of prematurity (rop) by the fda

ROP is a leading cause of childhood blindness worldwide EYLEA now approved to treat five retinal conditions caused by ocular angiogenesis TARRYTOWN, N...

February 8, 2023, 11:45 pm

Cara therapeutics announces results from the komfort phase 2 trial of oral difelikefalin for the treatment of pruritus in notalgia paresthetica published in the new england journal of medicine

Publication underscores the importance of data in underrecognized neuropathic itch disorder which lacks an approved treatment STAMFORD, Conn., Feb. 08...

February 8, 2023, 10:00 pm

Confused? the market is working through three main themes right now

The market is working through three main themes that are all significant departures from what markets were thinking about at the turn of the year.<...

February 8, 2023, 8:39 pm

Fed's williams: we still have some work to do to get inflation under control

• Asked about whether jobs data would change his view on terminal rates, he says December dot plot views are still 'very reasonable' due to tota...

  February 8, 2023, 2:24 pm

Erasca: potential strong upside ahead

Erasca, Inc. is a clinical-stage biopharmaceutical developer of therapies for patients with RAS/MAPK pathway-driven cancers. Shares were dragged down ...

February 8, 2023, 11:21 am

Is gold set for a ‘sympathy bounce’ towards 1900?

It was a tough end to the week for gold bugs which saw the yellow metal plunge 5% from its YTD high. Yet support was found just above the 50-day EMA, ...

February 8, 2023, 4:22 am

Gold price hangs tough as us dollar dominates proceedings. where to for xau/usd?

The gold price has mostly ignored the turmoil of US Dollar movements upending other markets this week as the Federal Reserve’s rate ...

February 8, 2023, 1:30 am

Fed kashkari: i haven’t seen anything yet to lower my rate path

Minneapolis Fed President Neel Kashkari told CNBC, “We have a job to do. We know that raising rates can put a lid on inflation. We need to raise rat...

February 7, 2023, 11:58 am

Fed's kashkari: if financial conditions are easier, we would have to do more on rates

• I am more cautious than markets on rate path
• Especially when there is still strong wage growth and other indicators
• Housing ma...

  February 7, 2023, 11:44 am

Fed's kashkari: nobody should overreact to one report

• Not changing my forecast for rates for now
• Still sees rate path moving towards around 5...

  February 7, 2023, 11:35 am

Valeo pharma obtains public reimbursement for onstryv in quebec expanding access to the drug for parkinson's patients

Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) said Onstryv (safinamide) for the treatment of patients with Parkinson's disease is now listed for reimbursem...

February 7, 2023, 9:01 am

Aud/usd and nzd/usd fundamental daily forecast – aussie firm after rba’s hawkish policy decisions

The RBA omitted its previous condition that policy was not on a “pre-set path”, suggesting further rate hikes were more likely than not. Read Full...

February 7, 2023, 7:59 am

Aud/usd and nzd/usd fundamental daily forecast – aussie firms after rba’s hawkish policy decisions

The RBA omitted its previous condition that policy was not on a “pre-set path”, suggesting further rate hikes were more likely than not. Read Full...

February 7, 2023, 7:14 am